Yulia’s expertise lies in the areas of materials engineering with specialism in biomedical and pharmaceutical engineering. She specialises in various aspects of materials manufacturing and technology with a particular emphasis on medical devices.
Yulia obtained her Masters (Hons) Degree in Chemistry from Tula State University, Russia in 2005.
She then worked for the Russian Police Force as a forensic expert/crime scene investigator, specialising in forensic analytical chemistry. In 2009 she moved to the UK to undertake her PhD in the chemistry of materials for the manufacturing of fine chemicals and commodities, which she completed in 2012.
In 2013-17 she worked as a Postdoctoral Researcher at the Universities of Sheffield and Bradford where she focused on managing a number of projects in the areas of biomedical and pharmaceutical engineering. Having worked in collaboration with several SMEs from both the UK and EU as part of her research activities, she used her experience and knowledge in the area of materials engineering and technology for orthopaedics and drug delivery systems to bridge the gap between industries and academia. She is an Associate Fellow of the Higher Education Academy since July 2016.
Yulia joined HGF in January 2018 as a Trainee Patent Attorney in the Sheffield office where she is currently working towards her qualification as a Patent Attorney.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.